Jiangsu Hengrui Medicine
600276.SS
#494
Rank
ยฃ32.35 B
Marketcap
ยฃ5.07
Share price
-0.62%
Change (1 day)
3.11%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ5.51 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are ยฃ5.51 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31ยฃ5.07 B11.19%
2021-12-31ยฃ4.56 B16.86%
2020-12-31ยฃ3.90 B29.86%
2019-12-31ยฃ3.00 B16.65%
2018-12-31ยฃ2.57 B25.69%
2017-12-31ยฃ2.05 B22.67%
2016-12-31ยฃ1.67 B39.73%
2015-12-31ยฃ1.19 B26.99%
2014-12-31ยฃ0.94 B30.32%
2013-12-31ยฃ0.72 B23.7%
2012-12-31ยฃ0.58 B18.56%
2011-12-31ยฃ0.49 B29.23%
2010-12-31ยฃ0.38 B40.66%
2009-12-31ยฃ0.27 B20.18%
2008-12-31ยฃ0.22 B58.97%
2007-12-31ยฃ0.14 B47.87%
2006-12-31ยฃ96.03 M3.97%
2005-12-31ยฃ92.37 M16.77%
2004-12-31ยฃ79.1 M-19.36%
2003-12-31ยฃ98.09 M8.08%
2002-12-31ยฃ90.76 M-2.66%
2001-12-31ยฃ93.25 M